A Clinical Trial Assessing the Impact of the Availability of Inhaled Insulin on Glucose Control

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.

ClinicalTrials.gov Identifier: NCT00134147

Recruitment Status : Completed

First Posted : August 24, 2005

Last Update Posted : April 17, 2008

View this study on Beta.ClinicalTrials.gov

Sponsor:

Collaborator:

Sanofi

Information provided by:

Pfizer

No Study Results Posted on ClinicalTrials.gov for this Study

About Study Results Reporting on ClinicalTrials.gov

Recruitment Status :	Completed
Primary Completion Date :	No date given
Actual Study Completion Date :	May 2007

Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):

Freemantle N, Strack TR; Real World Trialists. Will availability of inhaled human insulin (Exubera) improve management of type 2 diabetes? The design of the Real World trial. Trials. 2006 Aug 10;7:25. doi: 10.1186/1745-6215-7-25.

To Top